Sayyid, R.K., Dingar, D., Fleshner, K., Thorburn, T., Diamond, J., Yao, E., Hersey, K., Chadwick, K., Perlis, N., Klotz, L., Finelli, A., Hamilton, R., Kulkarni, G., Zlotta, A. and Fleshner, N. 2017. What false-negative rates of non-invasive testing are active surveillance patients and uro-oncologists willing to accept in order to avoid prostate biopsy?. Canadian Urological Association Journal. 11, 3-4 (Apr. 2017), 118–22. DOI:https://doi.org/10.5489/cuaj.4182.